The Food and Drug Administration approved Zepbound as the first prescription medicine to treat sleep apnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound ...

People whose sleep apnea changes dramatically from night to night are 30% more likely to have a heart attack, stroke, or ...

For starters you might not even snore.

If continuous positive airway pressure therapy isn’t working for your sleep apnea, nerve stimulation may be a game changer. Explore how this technology works, the latest devices, and what to expect ...

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

High nightly variability in obstructive sleep apnea severity is associated with increased risk for adverse cardio- and cerebrovascular events ...

Nearly 30 million adults in the U.S. have obstructive sleep apnea (OSA)—and many don't even know it. If you've been waking up ...

A Black woman sleeps peacefully surrounded by pills, charts, and various sleep devices. Sleep, the thing we all do each night ...

Many people assume sleep apnea is stable, but the reality is very different, and some nights can be much worse than others, ...

Sleep apnea is a pretty common diagnosis among people of a certain age, and about half of those tested are diagnosed with some version of it. Most of us probably consider it a potential health risk ...

Zepbound (tirzepatide) is a brand-name injection prescribed for treating sleep apnea. This article covers topics such as side effects, dosage, and how Zepbound works. Zepbound is available in ...